The prohibitin ligand IN44 decreases Porphyromonas gingivalis mediated inflammation
These findings suggest that PHBs may warrant consideration as therapeutic targets for periodontitis and possibly other inflammatory disorders.
Authors
- Nicolas Anton (ORCID: https://orcid.org/0000-0002-7047-9657)
- Céline Stutz (ORCID: https://orcid.org/0000-0003-0822-225X)
- Catherine Petit (ORCID: https://orcid.org/0000-0003-4565-3913)
- Pierre‐Yves Gegout (ORCID: https://orcid.org/0000-0002-4001-3784)
- Olivier Huck (ORCID: https://orcid.org/0000-0002-7988-2290)
- Laurent Désaubry (ORCID: https://orcid.org/0000-0002-1192-2970)
- Redouane Tabti
- Uğur Özçelik (ORCID: https://orcid.org/0000-0003-1587-5216)
- Chloé Bloch
Institutions
- Inserm (FR)
- Regenerative NanoMedicine (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Université de Strasbourg (FR)
Publication Details
- Journal
- BMC Oral Health
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1186/s12903-024-05209-2
- Primary Topic
- Oral microbiology and periodontitis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Institut Français pour la Recherche Odontologique